USE OF KINEMATIC ASSESSMENT OF HAND TREMOR PRE- AND POST-TREATMENT WITH BOTULINUM TOXIN TYPE A IN ESSENTIAL TREMOR AND PARKINSON DISEASE
- Registry ID
- 18445
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- LAWSON HEALTH RESEARCH INSTITUTE
- Start date
- 2011-11-08
- Last update
- 2015-06-26
Conditions
- ESSENTIAL TREMOR
- PARKINSON'S DISEASE
Related clinical trials
- A PHASE 2B MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY WITH AN OPEN-LABEL PERIOD TO EVALUATE THE EFFICACY AND SAFETY OF AGN 151607 DP (USAN: GEMIBOTULINUMTOXINA) FOR THE TREATMENT OF UPPER LIMB ESSENTIAL TREMOR IN ADULTS
- A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,
MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF
INTRAVENOUS PRASINEZUMAB IN PARTICIPANTS WITH EARLY STAGE PARKINSON’S DISEASE
- FIRST-IN-HUMAN STUDY TO EVALUATE THE SAFETY, TOLERABILITY,
PHARMACOKINETICS, AND PHARMACODYNAMICS OF SINGLE
ASCENDING DOSES OF INTRATHECALLY ADMINISTERED ALN-SNCA
IN PARTICIPANTS WITH EARLY PARKINSON¿S DISEASE
- PHASE 3 STUDY TO ASSESS THE EFFICACY AND SAFETY OF MIDBRAIN DOPAMINERGIC NEURONAL CELL THERAPY (BEMDANEPROCEL) FOR PARTICIPANTS WITH PARKINSON'S DISEASE
- TALLMAN FAMILY ENERGIZES RESEARCH TO HELP ALLEVIATE NEUROINFLAMMATION IN PARKINSONS DISEASE-"TALLER THAN PD". A PHASE 2 FUTILLITY STUDY TO EVALUATE THE EFFICACY,SAFETY AND TOLERABILITY OF HYDROXYCHLOROQUINE IN SUBJECT WITH EARLY TREATED PARKINSON'S DISEASE
- A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RANGE FINDING CLINICAL TRIAL TO EVALUATE THE TOLERABILITY, SAFETY, AND EFFICACY OF PRAX-944 IN THE TREATMENT OF ADULTS WITH ESSENTIAL TREMOR
View on source registry